Results 21 to 30 of about 7,679 (205)
Egyptian Journal of Chest Disease and Tuberculosis, 2013 Background and objective: Malignant pleural effusion (MPE) is a common problem in patients with malignancies. Chemical pleurodesis is the most commonly used palliative option.
Khaled H. Mohamed, Osama A. Hassan
doaj +2 more sources
Palliative Medicine in Practice, 2022 Pleurodesis is a definitive management strategy in malignant pleural effusion, its history is briefly described, and a narrative review is made about its indication, patient selection, response predictors and ...
Radhika Banka +2 more
core +4 more sources
Predictors of talc slurry pleurodesis success in patients with malignant pleural effusions
Revista Portuguesa de Pneumologia (English Edition), 2017 Introduction: Malignant pleural effusions are an important burden of malignant disease. Slurry talc pleurodesis remains one of the most common and effective therapeutic options.
P.S. Santos +4 more
doaj +2 more sources
Study of poly-ɛ-caprolactone membranes for pleurodesis
Journal of the Formosan Medical Association, 2017 Pleurodesis with biomaterial membrane is an emerging treatment method for pneumothorax. However, the ideal one for the common disease is still under debate.
Ke-Cheng Chen +7 more
doaj +2 more sources
Refractory Spontaneous Pneumothorax in Interstitial Lung Disease Under Pirfenidone Treatment [PDF]
Respirology Case ReportsRecurrent pneumothorax associated with interstitial lung disease occurs frequently. In the case of refractory pneumothorax, other methods such as mechanical pleurodesis, in addition to chemical pleurodesis, should be considered, because antifibrotics ...
Jaejun Jeong, Min Kyun Kang
doaj +2 more sources
The association of defective pleural sRAGE production with the recurrence of malignant pleural effusion after Talc pleurodesis [PDF]
Scientific ReportsSymptomatic malignant pleural effusions (MPE) are treated with chemical pleurodesis to prevent recurrence. The serum soluble receptor for advanced glycation end products (sRAGE) has been linked to lung cancer progression but its role in predicting talc ...
Kittipong Maneechotesuwan +4 more
doaj +2 more sources
Efficacy of mistletoe for chemical pleurodesis in rats without malignancy
Open Medicine, 2015 Chemical pleurodesis is an effective treatment modality to reduce recurrence of malignant effusion. Several agents have been used in chemical pleurodesis but, it is not yet clear which is better.
Ahn Hyo Yeong +6 more
doaj +2 more sources
Journal of Association of Pulmonologist of Tamil Nadu, 2021 Abstract The aim of pleurodesis is to seal visceral to parietal pleura with adhesions to prevent pleural fluid or air accumulating. Pleurodesis is dependent upon lung re-expansion following removal of pleural fluid or air, which allows the apposition of visceral and parietal pleura.
Stephen J. Chapman +4 more
+7 more sources
Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion [PDF]
Tuberculosis and Respiratory Diseases, 2021 Background Pleurodesis fails in 10%–40% of patients with recurrent malignant pleural effusions malignant pleural effusion and dyspnea. This study aimed to assess the values of pleural elastance (PEL) after the aspiration of 500 mL of pleural fluid and ...
Hossam Hosny Masoud +3 more
doaj +1 more source
The influence of tramadol and parecoxib on erythmyocin or bleomycin-induced pleurodesis in rabbit: a pilot study [PDF]
, 2021 Introduction: Recurrent pleural effusion secondary to advanced malignant diseases can lead to poor quality of life, recurrent hospital stays and increased hospital costs, which has yet to be extensively explored.
Nik Amin Sahid Nik Lah +6 more
core +1 more source